Recent advances in the prevention of hepatocellular carcinoma recurrence
LC Lu, AL Cheng, RTP Poon - Seminars in liver disease, 2014 - thieme-connect.com
Hepatocellular carcinoma (HCC) is one of the most lethal malignancies worldwide. Early-
stage HCC can be curatively treated, but the recurrence rate remains high. To date, adjuvant …
stage HCC can be curatively treated, but the recurrence rate remains high. To date, adjuvant …
[HTML][HTML] Molecular targeting agents associated with transarterial chemoembolization or radiofrequency ablation in hepatocarcinoma treatment
G Ranieri, I Marech, V Lorusso, V Goffredo… - World Journal of …, 2014 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cause of cancer in the world.
According to Barcelona Clinic Liver Cancer modified criteria, patients with early stage …
According to Barcelona Clinic Liver Cancer modified criteria, patients with early stage …
An open-label phase I/II study of tamibarotene in patients with advanced hepatocellular carcinoma
F Kanai, S Obi, S Fujiyama, S Shiina, H Tamai… - Hepatology …, 2014 - Springer
Aim Tamibarotene is a synthetic retinoid expected to inhibit tumor-cell proliferation and to
induce apoptosis by selective interaction with retinoic acid receptor α/β. We conducted an …
induce apoptosis by selective interaction with retinoic acid receptor α/β. We conducted an …
[PDF][PDF] Hepatocellular carcinoma chemotherapeutic agents: efficacy and mode of action
S Shaaban, A Negm, EE Ibrahim, AA Elrazak - Onc. Rev, 2014 - academia.edu
Accepted paper Page 1 This article has been accepted for publication and undergone full
peer review but has not been through the copyediting, typesetting, pagination and …
peer review but has not been through the copyediting, typesetting, pagination and …
Thalidomide induces complete remission of advanced hepatocellular carcinoma
CH Chien, RN Chien - Advances in Digestive Medicine, 2014 - Wiley Online Library
Hepatocellular carcinoma (HCC) is one of the most prevalent human cancers in the world,
but its prognosis is extremely poor. HCC is considered a hypervascular tumor. Thalidomide …
but its prognosis is extremely poor. HCC is considered a hypervascular tumor. Thalidomide …
Clinical Activity of Metronomic Chemotherapy in Liver Cancers
YY Shao, AL Cheng, CH Hsu - Metronomic Chemotherapy: Pharmacology …, 2014 - Springer
Treating advanced hepatocellular carcinoma (HCC) remains challenging in clinical practice.
Although sorafenib, an antiangiogenic targeted compound, has demonstrated survival …
Although sorafenib, an antiangiogenic targeted compound, has demonstrated survival …